Skip to search formSkip to main contentSkip to account menu

naftazone

Known as: 1,2-naphthoquinone-2-semicarbazone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
BACKGROUND Chronic venous insufficiency (CVI) is a common condition caused by valvular dysfunction with or without associated… 
2012
2012
In the present study substituted 1,2-naphthoquinones were synthesized, purified and characterized by spectroscopic studies (UV… 
2012
2012
To explore for the first time the tolerability and efficacy of naftazone in patients with Parkinson’s disease (PD). Proof‐of… 
Review
2005
Review
2005
BACKGROUND Chronic venous insufficiency (CVI) is a common condition caused by inadequate blood flow through the veins, usually in… 
1997
1997
Objective: To evaluate the effectiveness and best time course of prescription of 30 mg/day oral naftazone (N) in women with… 
1996
1996
Because of the considerable interest in the role of platelets and antiplatelet therapy in cardiovascular disease, including the… 
1995
1995
Reduction and glucuronidation of the vasoprotectant drug, naftazone, by human and rat liver microsomes and by recombinant UDP… 
1994
1994
Abstract— The preparation of hydrophilic matrix tablets able to release naftazone, a water‐insoluble drug, into an aqueous medium…